nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RXRA—ganglion—brain cancer	0.0201	0.0872	CbGeAlD
Acitretin—CYP26A1—endocrine gland—brain cancer	0.00794	0.0345	CbGeAlD
Acitretin—RXRA—telencephalon—brain cancer	0.00775	0.0337	CbGeAlD
Acitretin—RBP1—telencephalon—brain cancer	0.00752	0.0327	CbGeAlD
Acitretin—RXRB—telencephalon—brain cancer	0.00639	0.0278	CbGeAlD
Acitretin—RBP1—gonad—brain cancer	0.00628	0.0273	CbGeAlD
Acitretin—RBP1—pituitary gland—brain cancer	0.00612	0.0266	CbGeAlD
Acitretin—CYP26A1—brain—brain cancer	0.00568	0.0247	CbGeAlD
Acitretin—RXRG—pituitary gland—brain cancer	0.00554	0.0241	CbGeAlD
Acitretin—RBP1—midbrain—brain cancer	0.0054	0.0235	CbGeAlD
Acitretin—RXRG—medulla oblongata—brain cancer	0.00534	0.0232	CbGeAlD
Acitretin—RARA—telencephalon—brain cancer	0.00534	0.0232	CbGeAlD
Acitretin—RBP1—spinal cord—brain cancer	0.00527	0.0229	CbGeAlD
Acitretin—RXRA—endocrine gland—brain cancer	0.00489	0.0212	CbGeAlD
Acitretin—RXRG—midbrain—brain cancer	0.00488	0.0212	CbGeAlD
Acitretin—RXRA—head—brain cancer	0.00482	0.021	CbGeAlD
Acitretin—RXRG—spinal cord—brain cancer	0.00477	0.0207	CbGeAlD
Acitretin—RBP1—endocrine gland—brain cancer	0.00474	0.0206	CbGeAlD
Acitretin—RBP1—head—brain cancer	0.00468	0.0203	CbGeAlD
Acitretin—RARA—gonad—brain cancer	0.00445	0.0194	CbGeAlD
Acitretin—RXRA—central nervous system—brain cancer	0.0044	0.0191	CbGeAlD
Acitretin—RARB—endocrine gland—brain cancer	0.00439	0.0191	CbGeAlD
Acitretin—RARA—pituitary gland—brain cancer	0.00435	0.0189	CbGeAlD
Acitretin—RARB—head—brain cancer	0.00433	0.0188	CbGeAlD
Acitretin—RXRG—endocrine gland—brain cancer	0.00429	0.0186	CbGeAlD
Acitretin—RBP1—central nervous system—brain cancer	0.00427	0.0186	CbGeAlD
Acitretin—RXRG—head—brain cancer	0.00424	0.0184	CbGeAlD
Acitretin—RBP1—cerebellum—brain cancer	0.00418	0.0182	CbGeAlD
Acitretin—RXRB—endocrine gland—brain cancer	0.00403	0.0175	CbGeAlD
Acitretin—RXRB—head—brain cancer	0.00398	0.0173	CbGeAlD
Acitretin—Tretinoin—CYP2C9—brain cancer	0.00389	1	CrCbGaD
Acitretin—RARB—cerebellum—brain cancer	0.00387	0.0168	CbGeAlD
Acitretin—RXRG—central nervous system—brain cancer	0.00387	0.0168	CbGeAlD
Acitretin—RXRB—central nervous system—brain cancer	0.00363	0.0158	CbGeAlD
Acitretin—RXRB—cerebellum—brain cancer	0.00355	0.0154	CbGeAlD
Acitretin—RARG—head—brain cancer	0.00353	0.0154	CbGeAlD
Acitretin—RXRA—brain—brain cancer	0.0035	0.0152	CbGeAlD
Acitretin—RBP1—brain—brain cancer	0.00339	0.0147	CbGeAlD
Acitretin—RARA—endocrine gland—brain cancer	0.00337	0.0146	CbGeAlD
Acitretin—RARA—head—brain cancer	0.00332	0.0144	CbGeAlD
Acitretin—RARG—central nervous system—brain cancer	0.00323	0.014	CbGeAlD
Acitretin—RARG—cerebellum—brain cancer	0.00315	0.0137	CbGeAlD
Acitretin—RARB—brain—brain cancer	0.00314	0.0136	CbGeAlD
Acitretin—RXRG—brain—brain cancer	0.00307	0.0133	CbGeAlD
Acitretin—RARA—central nervous system—brain cancer	0.00303	0.0132	CbGeAlD
Acitretin—RARA—cerebellum—brain cancer	0.00296	0.0129	CbGeAlD
Acitretin—RXRB—brain—brain cancer	0.00289	0.0125	CbGeAlD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00278	0.0104	CbGpPWpGaD
Acitretin—RXRG—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00259	0.00965	CbGpPWpGaD
Acitretin—RARG—brain—brain cancer	0.00256	0.0111	CbGeAlD
Acitretin—RXRA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0025	0.00932	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.00246	0.00919	CbGpPWpGaD
Acitretin—RXRB—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00243	0.00907	CbGpPWpGaD
Acitretin—RARA—brain—brain cancer	0.00241	0.0105	CbGeAlD
Acitretin—RXRA—Orphan transporters—S100A10—brain cancer	0.0024	0.00893	CbGpPWpGaD
Acitretin—RXRA—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00232	0.00866	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00213	0.00794	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.00206	0.0077	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptors—ESR2—brain cancer	0.00205	0.00766	CbGpPWpGaD
Acitretin—RXRA—PPAR Alpha Pathway—CDK4—brain cancer	0.0017	0.00632	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.00163	0.00608	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00162	0.00605	CbGpPWpGaD
Acitretin—Flushing—Procarbazine—brain cancer	0.00154	0.0031	CcSEcCtD
Acitretin—Dermatitis exfoliative—Temozolomide—brain cancer	0.00154	0.00309	CcSEcCtD
Acitretin—Menopausal symptoms—Temozolomide—brain cancer	0.00154	0.00309	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.00153	0.00571	CbGpPWpGaD
Acitretin—Candida infection—Etoposide—brain cancer	0.00153	0.00307	CcSEcCtD
Acitretin—Skin exfoliation—Etoposide—brain cancer	0.00153	0.00307	CcSEcCtD
Acitretin—Thirst—Temozolomide—brain cancer	0.00152	0.00306	CcSEcCtD
Acitretin—Pancytopenia—Hydroxyurea—brain cancer	0.00152	0.00306	CcSEcCtD
Acitretin—Purpura—Temozolomide—brain cancer	0.00151	0.00302	CcSEcCtD
Acitretin—Diplopia—Carmustine—brain cancer	0.0015	0.00302	CcSEcCtD
Acitretin—Dysuria—Hydroxyurea—brain cancer	0.0015	0.00302	CcSEcCtD
Acitretin—Chills—Procarbazine—brain cancer	0.00149	0.00299	CcSEcCtD
Acitretin—Body temperature increased—Lomustine—brain cancer	0.00147	0.00295	CcSEcCtD
Acitretin—Alopecia—Procarbazine—brain cancer	0.00147	0.00295	CcSEcCtD
Acitretin—Oesophagitis—Etoposide—brain cancer	0.00146	0.00294	CcSEcCtD
Acitretin—Weight increased—Hydroxyurea—brain cancer	0.00146	0.00293	CcSEcCtD
Acitretin—Diplopia—Temozolomide—brain cancer	0.00145	0.00291	CcSEcCtD
Acitretin—Mouth ulceration—Etoposide—brain cancer	0.00145	0.00291	CcSEcCtD
Acitretin—Tension—Procarbazine—brain cancer	0.00142	0.00285	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00141	0.00526	CbGpPWpGaD
Acitretin—Nervousness—Procarbazine—brain cancer	0.0014	0.00282	CcSEcCtD
Acitretin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.0014	0.00282	CcSEcCtD
Acitretin—Stomatitis—Hydroxyurea—brain cancer	0.00139	0.0028	CcSEcCtD
Acitretin—Liver function test abnormal—Carmustine—brain cancer	0.00139	0.00278	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.00138	0.00513	CbGpPWpGaD
Acitretin—ALB—brain—brain cancer	0.00136	0.0059	CbGeAlD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00135	0.00505	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—IRS2—brain cancer	0.00134	0.00501	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00134	0.00499	CbGpPWpGaD
Acitretin—Dry skin—Temozolomide—brain cancer	0.00133	0.00267	CcSEcCtD
Acitretin—RXRA—Biological oxidations—CYP2C9—brain cancer	0.00133	0.00495	CbGpPWpGaD
Acitretin—RBP1—Disease—DTX2—brain cancer	0.00133	0.00494	CbGpPWpGaD
Acitretin—Muscular weakness—Carmustine—brain cancer	0.00132	0.00266	CcSEcCtD
Acitretin—Haemoglobin—Hydroxyurea—brain cancer	0.00129	0.00259	CcSEcCtD
Acitretin—Haemorrhage—Hydroxyurea—brain cancer	0.00128	0.00258	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00128	0.00478	CbGpPWpGaD
Acitretin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.00128	0.00477	CbGpPWpGaD
Acitretin—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00128	0.00257	CcSEcCtD
Acitretin—Muscular weakness—Temozolomide—brain cancer	0.00128	0.00257	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00127	0.00473	CbGpPWpGaD
Acitretin—Cough—Procarbazine—brain cancer	0.00126	0.00253	CcSEcCtD
Acitretin—Pancytopenia—Carmustine—brain cancer	0.00123	0.00248	CcSEcCtD
Acitretin—Arthralgia—Procarbazine—brain cancer	0.00123	0.00247	CcSEcCtD
Acitretin—Myalgia—Procarbazine—brain cancer	0.00123	0.00247	CcSEcCtD
Acitretin—Anxiety—Procarbazine—brain cancer	0.00123	0.00246	CcSEcCtD
Acitretin—Sweating increased—Temozolomide—brain cancer	0.00122	0.00245	CcSEcCtD
Acitretin—Dry mouth—Procarbazine—brain cancer	0.0012	0.00242	CcSEcCtD
Acitretin—Pancytopenia—Temozolomide—brain cancer	0.00119	0.00239	CcSEcCtD
Acitretin—Vomiting—Lomustine—brain cancer	0.00118	0.00237	CcSEcCtD
Acitretin—Oedema—Procarbazine—brain cancer	0.00118	0.00237	CcSEcCtD
Acitretin—Dysuria—Temozolomide—brain cancer	0.00117	0.00236	CcSEcCtD
Acitretin—Infection—Procarbazine—brain cancer	0.00117	0.00235	CcSEcCtD
Acitretin—Angiopathy—Hydroxyurea—brain cancer	0.00117	0.00234	CcSEcCtD
Acitretin—Erectile dysfunction—Temozolomide—brain cancer	0.00115	0.00232	CcSEcCtD
Acitretin—Depression—Carmustine—brain cancer	0.00115	0.00232	CcSEcCtD
Acitretin—Chills—Hydroxyurea—brain cancer	0.00115	0.00232	CcSEcCtD
Acitretin—Photosensitivity reaction—Temozolomide—brain cancer	0.00114	0.0023	CcSEcCtD
Acitretin—Weight increased—Temozolomide—brain cancer	0.00114	0.00229	CcSEcCtD
Acitretin—Hyperhidrosis—Procarbazine—brain cancer	0.00114	0.00229	CcSEcCtD
Acitretin—Alopecia—Hydroxyurea—brain cancer	0.00114	0.00228	CcSEcCtD
Acitretin—Weight decreased—Temozolomide—brain cancer	0.00113	0.00228	CcSEcCtD
Acitretin—Neuropathy peripheral—Carmustine—brain cancer	0.00113	0.00228	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.00113	0.00421	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00113	0.00421	CbGpPWpGaD
Acitretin—Stomatitis—Carmustine—brain cancer	0.00113	0.00227	CcSEcCtD
Acitretin—Urinary tract infection—Carmustine—brain cancer	0.00112	0.00226	CcSEcCtD
Acitretin—Anorexia—Procarbazine—brain cancer	0.00112	0.00226	CcSEcCtD
Acitretin—Erythema—Hydroxyurea—brain cancer	0.00112	0.00225	CcSEcCtD
Acitretin—Depression—Temozolomide—brain cancer	0.00111	0.00224	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.0011	0.00411	CbGpPWpGaD
Acitretin—Nausea—Lomustine—brain cancer	0.0011	0.00222	CcSEcCtD
Acitretin—Neuropathy peripheral—Temozolomide—brain cancer	0.0011	0.0022	CcSEcCtD
Acitretin—RXRA—PPAR Alpha Pathway—CCND1—brain cancer	0.00109	0.00408	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—OR14C36—brain cancer	0.00109	0.00407	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—OR4C12—brain cancer	0.00109	0.00407	CbGpPWpGaD
Acitretin—Stomatitis—Temozolomide—brain cancer	0.00109	0.00219	CcSEcCtD
Acitretin—Urinary tract infection—Temozolomide—brain cancer	0.00109	0.00218	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00108	0.00404	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00107	0.00216	CcSEcCtD
Acitretin—Insomnia—Procarbazine—brain cancer	0.00107	0.00214	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.00106	0.00396	CbGpPWpGaD
Acitretin—Paraesthesia—Procarbazine—brain cancer	0.00106	0.00213	CcSEcCtD
Acitretin—Sinusitis—Temozolomide—brain cancer	0.00105	0.00211	CcSEcCtD
Acitretin—Somnolence—Procarbazine—brain cancer	0.00105	0.00211	CcSEcCtD
Acitretin—Haemoglobin—Carmustine—brain cancer	0.00104	0.0021	CcSEcCtD
Acitretin—Haemorrhage—Carmustine—brain cancer	0.00104	0.00209	CcSEcCtD
Acitretin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00104	0.00208	CcSEcCtD
Acitretin—Hypoaesthesia—Carmustine—brain cancer	0.00103	0.00208	CcSEcCtD
Acitretin—Decreased appetite—Procarbazine—brain cancer	0.00103	0.00206	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Etoposide—brain cancer	0.00102	0.00206	CcSEcCtD
Acitretin—Oedema peripheral—Carmustine—brain cancer	0.00102	0.00206	CcSEcCtD
Acitretin—RXRG—Adipogenesis—IRS2—brain cancer	0.00102	0.00379	CbGpPWpGaD
Acitretin—Fatigue—Procarbazine—brain cancer	0.00102	0.00204	CcSEcCtD
Acitretin—Haemoglobin—Temozolomide—brain cancer	0.00101	0.00203	CcSEcCtD
Acitretin—Malaise—Hydroxyurea—brain cancer	0.00101	0.00203	CcSEcCtD
Acitretin—Constipation—Procarbazine—brain cancer	0.00101	0.00203	CcSEcCtD
Acitretin—Pain—Procarbazine—brain cancer	0.00101	0.00203	CcSEcCtD
Acitretin—Haemorrhage—Temozolomide—brain cancer	0.001	0.00202	CcSEcCtD
Acitretin—Hepatitis—Temozolomide—brain cancer	0.001	0.00202	CcSEcCtD
Acitretin—Visual impairment—Carmustine—brain cancer	0.001	0.00201	CcSEcCtD
Acitretin—Hypoaesthesia—Temozolomide—brain cancer	0.000999	0.00201	CcSEcCtD
Acitretin—Pharyngitis—Temozolomide—brain cancer	0.000996	0.002	CcSEcCtD
Acitretin—Oedema peripheral—Temozolomide—brain cancer	0.000989	0.00199	CcSEcCtD
Acitretin—Sweating increased—Etoposide—brain cancer	0.000977	0.00196	CcSEcCtD
Acitretin—RBP1—Disease—HES5—brain cancer	0.000973	0.00363	CbGpPWpGaD
Acitretin—Feeling abnormal—Procarbazine—brain cancer	0.000972	0.00195	CcSEcCtD
Acitretin—Eye disorder—Carmustine—brain cancer	0.000971	0.00195	CcSEcCtD
Acitretin—Visual impairment—Temozolomide—brain cancer	0.000967	0.00194	CcSEcCtD
Acitretin—Gastrointestinal pain—Procarbazine—brain cancer	0.000964	0.00194	CcSEcCtD
Acitretin—Flushing—Carmustine—brain cancer	0.000964	0.00194	CcSEcCtD
Acitretin—RARA—Adipogenesis—IRS2—brain cancer	0.000957	0.00357	CbGpPWpGaD
Acitretin—Pancytopenia—Etoposide—brain cancer	0.000953	0.00191	CcSEcCtD
Acitretin—Discomfort—Hydroxyurea—brain cancer	0.000941	0.00189	CcSEcCtD
Acitretin—Eye disorder—Temozolomide—brain cancer	0.000938	0.00188	CcSEcCtD
Acitretin—Urticaria—Procarbazine—brain cancer	0.000937	0.00188	CcSEcCtD
Acitretin—Tinnitus—Temozolomide—brain cancer	0.000936	0.00188	CcSEcCtD
Acitretin—Body temperature increased—Procarbazine—brain cancer	0.000932	0.00187	CcSEcCtD
Acitretin—Abdominal pain—Procarbazine—brain cancer	0.000932	0.00187	CcSEcCtD
Acitretin—Flushing—Temozolomide—brain cancer	0.000931	0.00187	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—DTX2—brain cancer	0.000928	0.00346	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000928	0.00346	CbGpPWpGaD
Acitretin—Alopecia—Carmustine—brain cancer	0.000918	0.00184	CcSEcCtD
Acitretin—Oedema—Hydroxyurea—brain cancer	0.000913	0.00183	CcSEcCtD
Acitretin—Angiopathy—Temozolomide—brain cancer	0.000911	0.00183	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00091	0.00339	CbGpPWpGaD
Acitretin—Infection—Hydroxyurea—brain cancer	0.000907	0.00182	CcSEcCtD
Acitretin—Immune system disorder—Temozolomide—brain cancer	0.000907	0.00182	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000906	0.00338	CbGpPWpGaD
Acitretin—Erythema—Carmustine—brain cancer	0.000904	0.00182	CcSEcCtD
Acitretin—Chills—Temozolomide—brain cancer	0.000901	0.00181	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000899	0.00335	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00089	0.00332	CbGpPWpGaD
Acitretin—Alopecia—Temozolomide—brain cancer	0.000887	0.00178	CcSEcCtD
Acitretin—Skin disorder—Hydroxyurea—brain cancer	0.000887	0.00178	CcSEcCtD
Acitretin—RXRA—PPAR Alpha Pathway—MYC—brain cancer	0.000878	0.00327	CbGpPWpGaD
Acitretin—Neuropathy peripheral—Etoposide—brain cancer	0.000877	0.00176	CcSEcCtD
Acitretin—Back pain—Carmustine—brain cancer	0.000875	0.00176	CcSEcCtD
Acitretin—Erythema—Temozolomide—brain cancer	0.000874	0.00176	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000872	0.00325	CbGpPWpGaD
Acitretin—Stomatitis—Etoposide—brain cancer	0.000872	0.00175	CcSEcCtD
Acitretin—Jaundice—Etoposide—brain cancer	0.000872	0.00175	CcSEcCtD
Acitretin—Anorexia—Hydroxyurea—brain cancer	0.00087	0.00175	CcSEcCtD
Acitretin—Hypersensitivity—Procarbazine—brain cancer	0.000869	0.00175	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000862	0.00321	CbGpPWpGaD
Acitretin—Dysgeusia—Temozolomide—brain cancer	0.000856	0.00172	CcSEcCtD
Acitretin—Vision blurred—Carmustine—brain cancer	0.000852	0.00171	CcSEcCtD
Acitretin—Asthenia—Procarbazine—brain cancer	0.000846	0.0017	CcSEcCtD
Acitretin—Back pain—Temozolomide—brain cancer	0.000845	0.0017	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000835	0.00311	CbGpPWpGaD
Acitretin—Pruritus—Procarbazine—brain cancer	0.000834	0.00168	CcSEcCtD
Acitretin—Vision blurred—Temozolomide—brain cancer	0.000823	0.00165	CcSEcCtD
Acitretin—Somnolence—Hydroxyurea—brain cancer	0.000811	0.00163	CcSEcCtD
Acitretin—Ill-defined disorder—Temozolomide—brain cancer	0.000811	0.00163	CcSEcCtD
Acitretin—Diarrhoea—Procarbazine—brain cancer	0.000807	0.00162	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—CTNNB1—brain cancer	0.000805	0.003	CbGpPWpGaD
Acitretin—Dyspepsia—Hydroxyurea—brain cancer	0.000803	0.00161	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000801	0.00299	CbGpPWpGaD
Acitretin—Hypoaesthesia—Etoposide—brain cancer	0.000799	0.00161	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.000799	0.00298	CbGpPWpGaD
Acitretin—Angioedema—Temozolomide—brain cancer	0.000798	0.0016	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000796	0.00297	CbGpPWpGaD
Acitretin—Decreased appetite—Hydroxyurea—brain cancer	0.000793	0.00159	CcSEcCtD
Acitretin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000788	0.00158	CcSEcCtD
Acitretin—Malaise—Temozolomide—brain cancer	0.000788	0.00158	CcSEcCtD
Acitretin—Fatigue—Hydroxyurea—brain cancer	0.000787	0.00158	CcSEcCtD
Acitretin—Pain—Hydroxyurea—brain cancer	0.000781	0.00157	CcSEcCtD
Acitretin—Constipation—Hydroxyurea—brain cancer	0.000781	0.00157	CcSEcCtD
Acitretin—Dizziness—Procarbazine—brain cancer	0.00078	0.00157	CcSEcCtD
Acitretin—Myalgia—Carmustine—brain cancer	0.00077	0.00155	CcSEcCtD
Acitretin—Chest pain—Carmustine—brain cancer	0.00077	0.00155	CcSEcCtD
Acitretin—Anxiety—Carmustine—brain cancer	0.000767	0.00154	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000763	0.00285	CbGpPWpGaD
Acitretin—Cough—Temozolomide—brain cancer	0.000762	0.00153	CcSEcCtD
Acitretin—Feeling abnormal—Hydroxyurea—brain cancer	0.000752	0.00151	CcSEcCtD
Acitretin—Eye disorder—Etoposide—brain cancer	0.000751	0.00151	CcSEcCtD
Acitretin—Vomiting—Procarbazine—brain cancer	0.00075	0.00151	CcSEcCtD
Acitretin—Flushing—Etoposide—brain cancer	0.000745	0.0015	CcSEcCtD
Acitretin—Myalgia—Temozolomide—brain cancer	0.000744	0.00149	CcSEcCtD
Acitretin—Arthralgia—Temozolomide—brain cancer	0.000744	0.00149	CcSEcCtD
Acitretin—Rash—Procarbazine—brain cancer	0.000744	0.00149	CcSEcCtD
Acitretin—Dermatitis—Procarbazine—brain cancer	0.000743	0.00149	CcSEcCtD
Acitretin—Anxiety—Temozolomide—brain cancer	0.000741	0.00149	CcSEcCtD
Acitretin—Headache—Procarbazine—brain cancer	0.000739	0.00148	CcSEcCtD
Acitretin—Oedema—Carmustine—brain cancer	0.000738	0.00148	CcSEcCtD
Acitretin—Discomfort—Temozolomide—brain cancer	0.000735	0.00148	CcSEcCtD
Acitretin—Infection—Carmustine—brain cancer	0.000733	0.00147	CcSEcCtD
Acitretin—Angiopathy—Etoposide—brain cancer	0.000729	0.00146	CcSEcCtD
Acitretin—Dry mouth—Temozolomide—brain cancer	0.000727	0.00146	CcSEcCtD
Acitretin—Immune system disorder—Etoposide—brain cancer	0.000725	0.00146	CcSEcCtD
Acitretin—Body temperature increased—Hydroxyurea—brain cancer	0.000722	0.00145	CcSEcCtD
Acitretin—Chills—Etoposide—brain cancer	0.000721	0.00145	CcSEcCtD
Acitretin—Oedema—Temozolomide—brain cancer	0.000713	0.00143	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000711	0.00265	CbGpPWpGaD
Acitretin—Alopecia—Etoposide—brain cancer	0.00071	0.00143	CcSEcCtD
Acitretin—Infection—Temozolomide—brain cancer	0.000708	0.00142	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000706	0.00263	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTCH2—brain cancer	0.000703	0.00262	CbGpPWpGaD
Acitretin—Anorexia—Carmustine—brain cancer	0.000703	0.00141	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—STAT3—brain cancer	0.000702	0.00262	CbGpPWpGaD
Acitretin—Nausea—Procarbazine—brain cancer	0.000701	0.00141	CcSEcCtD
Acitretin—Skin disorder—Temozolomide—brain cancer	0.000693	0.00139	CcSEcCtD
Acitretin—Hyperhidrosis—Temozolomide—brain cancer	0.000689	0.00138	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000688	0.00257	CbGpPWpGaD
Acitretin—Dysgeusia—Etoposide—brain cancer	0.000685	0.00138	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—HES5—brain cancer	0.000681	0.00254	CbGpPWpGaD
Acitretin—Anorexia—Temozolomide—brain cancer	0.00068	0.00137	CcSEcCtD
Acitretin—Back pain—Etoposide—brain cancer	0.000676	0.00136	CcSEcCtD
Acitretin—Hypersensitivity—Hydroxyurea—brain cancer	0.000672	0.00135	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000672	0.00135	CcSEcCtD
Acitretin—Muscle spasms—Etoposide—brain cancer	0.000672	0.00135	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000669	0.00249	CbGpPWpGaD
Acitretin—Insomnia—Carmustine—brain cancer	0.000667	0.00134	CcSEcCtD
Acitretin—Paraesthesia—Carmustine—brain cancer	0.000663	0.00133	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—STRADA—brain cancer	0.000661	0.00247	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00066	0.00246	CbGpPWpGaD
Acitretin—Somnolence—Carmustine—brain cancer	0.000656	0.00132	CcSEcCtD
Acitretin—Asthenia—Hydroxyurea—brain cancer	0.000655	0.00132	CcSEcCtD
Acitretin—RBP1—Disease—IDH1—brain cancer	0.000655	0.00244	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00065	0.00131	CcSEcCtD
Acitretin—Ill-defined disorder—Etoposide—brain cancer	0.000649	0.0013	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000648	0.00242	CbGpPWpGaD
Acitretin—Insomnia—Temozolomide—brain cancer	0.000645	0.0013	CcSEcCtD
Acitretin—Decreased appetite—Carmustine—brain cancer	0.000641	0.00129	CcSEcCtD
Acitretin—Paraesthesia—Temozolomide—brain cancer	0.00064	0.00129	CcSEcCtD
Acitretin—Gastrointestinal disorder—Carmustine—brain cancer	0.000637	0.00128	CcSEcCtD
Acitretin—Somnolence—Temozolomide—brain cancer	0.000634	0.00127	CcSEcCtD
Acitretin—Pain—Carmustine—brain cancer	0.000631	0.00127	CcSEcCtD
Acitretin—Constipation—Carmustine—brain cancer	0.000631	0.00127	CcSEcCtD
Acitretin—Malaise—Etoposide—brain cancer	0.00063	0.00127	CcSEcCtD
Acitretin—Dyspepsia—Temozolomide—brain cancer	0.000628	0.00126	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—ESR2—brain cancer	0.000626	0.00233	CbGpPWpGaD
Acitretin—Diarrhoea—Hydroxyurea—brain cancer	0.000625	0.00125	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000624	0.00233	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000621	0.00232	CbGpPWpGaD
Acitretin—RBP1—Disease—HEY1—brain cancer	0.000621	0.00231	CbGpPWpGaD
Acitretin—Decreased appetite—Temozolomide—brain cancer	0.00062	0.00125	CcSEcCtD
Acitretin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000616	0.00124	CcSEcCtD
Acitretin—Fatigue—Temozolomide—brain cancer	0.000615	0.00124	CcSEcCtD
Acitretin—CYP26A1—Metabolism—CYP2C9—brain cancer	0.000611	0.00228	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—CTNNB1—brain cancer	0.00061	0.00228	CbGpPWpGaD
Acitretin—Cough—Etoposide—brain cancer	0.00061	0.00123	CcSEcCtD
Acitretin—Pain—Temozolomide—brain cancer	0.00061	0.00123	CcSEcCtD
Acitretin—Constipation—Temozolomide—brain cancer	0.00061	0.00123	CcSEcCtD
Acitretin—RBP1—Disease—DLL1—brain cancer	0.000609	0.00227	CbGpPWpGaD
Acitretin—Feeling abnormal—Carmustine—brain cancer	0.000608	0.00122	CcSEcCtD
Acitretin—Dizziness—Hydroxyurea—brain cancer	0.000604	0.00121	CcSEcCtD
Acitretin—Gastrointestinal pain—Carmustine—brain cancer	0.000603	0.00121	CcSEcCtD
Acitretin—Chest pain—Etoposide—brain cancer	0.000595	0.0012	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—NOTCH2—brain cancer	0.000593	0.00221	CbGpPWpGaD
Acitretin—Discomfort—Etoposide—brain cancer	0.000588	0.00118	CcSEcCtD
Acitretin—Feeling abnormal—Temozolomide—brain cancer	0.000588	0.00118	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—S100A10—brain cancer	0.000585	0.00218	CbGpPWpGaD
Acitretin—Body temperature increased—Carmustine—brain cancer	0.000583	0.00117	CcSEcCtD
Acitretin—Abdominal pain—Carmustine—brain cancer	0.000583	0.00117	CcSEcCtD
Acitretin—Gastrointestinal pain—Temozolomide—brain cancer	0.000583	0.00117	CcSEcCtD
Acitretin—Vomiting—Hydroxyurea—brain cancer	0.00058	0.00117	CcSEcCtD
Acitretin—Rash—Hydroxyurea—brain cancer	0.000575	0.00116	CcSEcCtD
Acitretin—Dermatitis—Hydroxyurea—brain cancer	0.000575	0.00116	CcSEcCtD
Acitretin—RARA—Adipogenesis—CTNNB1—brain cancer	0.000574	0.00214	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000574	0.00214	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—ESR2—brain cancer	0.000572	0.00213	CbGpPWpGaD
Acitretin—Headache—Hydroxyurea—brain cancer	0.000572	0.00115	CcSEcCtD
Acitretin—Infection—Etoposide—brain cancer	0.000567	0.00114	CcSEcCtD
Acitretin—Urticaria—Temozolomide—brain cancer	0.000566	0.00114	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000565	0.0021	CbGpPWpGaD
Acitretin—Abdominal pain—Temozolomide—brain cancer	0.000564	0.00113	CcSEcCtD
Acitretin—Body temperature increased—Temozolomide—brain cancer	0.000564	0.00113	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—ESR2—brain cancer	0.000561	0.00209	CbGpPWpGaD
Acitretin—Skin disorder—Etoposide—brain cancer	0.000554	0.00111	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.000554	0.00206	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ABR—brain cancer	0.000552	0.00206	CbGpPWpGaD
Acitretin—Hyperhidrosis—Etoposide—brain cancer	0.000552	0.00111	CcSEcCtD
Acitretin—Anorexia—Etoposide—brain cancer	0.000544	0.00109	CcSEcCtD
Acitretin—Hypersensitivity—Carmustine—brain cancer	0.000544	0.00109	CcSEcCtD
Acitretin—Nausea—Hydroxyurea—brain cancer	0.000542	0.00109	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—NOTCH2—brain cancer	0.000542	0.00202	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—ESR2—brain cancer	0.000538	0.00201	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—ESR2—brain cancer	0.000538	0.00201	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GLI2—brain cancer	0.000533	0.00199	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—STAT3—brain cancer	0.000532	0.00198	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—NOTCH2—brain cancer	0.000532	0.00198	CbGpPWpGaD
Acitretin—Asthenia—Carmustine—brain cancer	0.000529	0.00106	CcSEcCtD
Acitretin—Hypersensitivity—Temozolomide—brain cancer	0.000525	0.00106	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.000523	0.00195	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—BSG—brain cancer	0.00052	0.00194	CbGpPWpGaD
Acitretin—RBP1—Disease—SHH—brain cancer	0.000518	0.00193	CbGpPWpGaD
Acitretin—RBP1—Disease—ENO2—brain cancer	0.000518	0.00193	CbGpPWpGaD
Acitretin—Paraesthesia—Etoposide—brain cancer	0.000512	0.00103	CcSEcCtD
Acitretin—Asthenia—Temozolomide—brain cancer	0.000512	0.00103	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00051	0.0019	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—NOTCH2—brain cancer	0.00051	0.0019	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—NOTCH2—brain cancer	0.00051	0.0019	CbGpPWpGaD
Acitretin—Somnolence—Etoposide—brain cancer	0.000507	0.00102	CcSEcCtD
Acitretin—Diarrhoea—Carmustine—brain cancer	0.000505	0.00101	CcSEcCtD
Acitretin—Pruritus—Temozolomide—brain cancer	0.000504	0.00101	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000503	0.00188	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GLI1—brain cancer	0.000501	0.00187	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—STAT3—brain cancer	0.0005	0.00187	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—IRS2—brain cancer	0.000499	0.00186	CbGpPWpGaD
Acitretin—Decreased appetite—Etoposide—brain cancer	0.000496	0.000997	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—brain cancer	0.000493	0.00099	CcSEcCtD
Acitretin—Fatigue—Etoposide—brain cancer	0.000492	0.000988	CcSEcCtD
Acitretin—Dizziness—Carmustine—brain cancer	0.000488	0.00098	CcSEcCtD
Acitretin—Pain—Etoposide—brain cancer	0.000488	0.00098	CcSEcCtD
Acitretin—Constipation—Etoposide—brain cancer	0.000488	0.00098	CcSEcCtD
Acitretin—Diarrhoea—Temozolomide—brain cancer	0.000488	0.00098	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000482	0.0018	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SUFU—brain cancer	0.000475	0.00177	CbGpPWpGaD
Acitretin—Dizziness—Temozolomide—brain cancer	0.000472	0.000947	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—brain cancer	0.00047	0.000945	CcSEcCtD
Acitretin—Vomiting—Carmustine—brain cancer	0.000469	0.000943	CcSEcCtD
Acitretin—ALB—Folate Metabolism—SOD2—brain cancer	0.000467	0.00174	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Etoposide—brain cancer	0.000467	0.000937	CcSEcCtD
Acitretin—Rash—Carmustine—brain cancer	0.000465	0.000935	CcSEcCtD
Acitretin—Dermatitis—Carmustine—brain cancer	0.000465	0.000934	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000464	0.00173	CbGpPWpGaD
Acitretin—Headache—Carmustine—brain cancer	0.000462	0.000929	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—GFAP—brain cancer	0.000458	0.00171	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000455	0.0017	CbGpPWpGaD
Acitretin—Vomiting—Temozolomide—brain cancer	0.000453	0.000911	CcSEcCtD
Acitretin—Urticaria—Etoposide—brain cancer	0.000453	0.000911	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—brain cancer	0.000451	0.000906	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—brain cancer	0.000451	0.000906	CcSEcCtD
Acitretin—Rash—Temozolomide—brain cancer	0.00045	0.000903	CcSEcCtD
Acitretin—Dermatitis—Temozolomide—brain cancer	0.000449	0.000902	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000449	0.00167	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—IDH1—brain cancer	0.000447	0.00167	CbGpPWpGaD
Acitretin—Headache—Temozolomide—brain cancer	0.000447	0.000897	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000444	0.00166	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.00044	0.00164	CbGpPWpGaD
Acitretin—Nausea—Carmustine—brain cancer	0.000438	0.000881	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—HEY1—brain cancer	0.000435	0.00162	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—DLL1—brain cancer	0.000426	0.00159	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000426	0.00159	CbGpPWpGaD
Acitretin—Nausea—Temozolomide—brain cancer	0.000424	0.000851	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000422	0.00157	CbGpPWpGaD
Acitretin—Hypersensitivity—Etoposide—brain cancer	0.00042	0.000845	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000417	0.00156	CbGpPWpGaD
Acitretin—Asthenia—Etoposide—brain cancer	0.000409	0.000823	CcSEcCtD
Acitretin—Pruritus—Etoposide—brain cancer	0.000404	0.000811	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000398	0.00148	CbGpPWpGaD
Acitretin—Diarrhoea—Etoposide—brain cancer	0.00039	0.000784	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000387	0.00144	CbGpPWpGaD
Acitretin—Dizziness—Etoposide—brain cancer	0.000377	0.000758	CcSEcCtD
Acitretin—RBP1—Disease—VAV1—brain cancer	0.000374	0.00139	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000373	0.00139	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000371	0.00138	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000371	0.00138	CbGpPWpGaD
Acitretin—Vomiting—Etoposide—brain cancer	0.000363	0.000729	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—SHH—brain cancer	0.000362	0.00135	CbGpPWpGaD
Acitretin—Rash—Etoposide—brain cancer	0.00036	0.000723	CcSEcCtD
Acitretin—Dermatitis—Etoposide—brain cancer	0.000359	0.000722	CcSEcCtD
Acitretin—Headache—Etoposide—brain cancer	0.000357	0.000718	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000356	0.00133	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ENO2—brain cancer	0.000353	0.00132	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TRPC6—brain cancer	0.000349	0.0013	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000349	0.0013	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000344	0.00128	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTCH1—brain cancer	0.000344	0.00128	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SMO—brain cancer	0.000344	0.00128	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000342	0.00127	CbGpPWpGaD
Acitretin—Nausea—Etoposide—brain cancer	0.000339	0.000681	CcSEcCtD
Acitretin—RARG—Gene Expression—DNMT1—brain cancer	0.000336	0.00125	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000334	0.00125	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.000332	0.00124	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000324	0.00121	CbGpPWpGaD
Acitretin—RBP1—Disease—HES1—brain cancer	0.000322	0.0012	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MPL—brain cancer	0.000321	0.0012	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TRPC6—brain cancer	0.000318	0.00119	CbGpPWpGaD
Acitretin—ALB—Hemostasis—S100A10—brain cancer	0.000308	0.00115	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—DNMT1—brain cancer	0.000307	0.00114	CbGpPWpGaD
Acitretin—RBP1—Disease—PDGFRA—brain cancer	0.000306	0.00114	CbGpPWpGaD
Acitretin—RARG—Gene Expression—ESR2—brain cancer	0.000301	0.00112	CbGpPWpGaD
Acitretin—RARB—Gene Expression—DNMT1—brain cancer	0.000301	0.00112	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CTNNB1—brain cancer	0.000299	0.00112	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000293	0.00109	CbGpPWpGaD
Acitretin—RARA—Gene Expression—DNMT1—brain cancer	0.000289	0.00108	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—DNMT1—brain cancer	0.000289	0.00108	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH2—brain cancer	0.000285	0.00106	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000281	0.00105	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR2—brain cancer	0.00028	0.00105	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000276	0.00103	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—ESR2—brain cancer	0.000276	0.00103	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH2—brain cancer	0.000275	0.00102	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ESR2—brain cancer	0.00027	0.00101	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00027	0.00101	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—RELA—brain cancer	0.00027	0.00101	CbGpPWpGaD
Acitretin—RBP1—Disease—IRS2—brain cancer	0.000269	0.001	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000267	0.000995	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH2—brain cancer	0.000266	0.00099	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VAV1—brain cancer	0.000262	0.000976	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH2—brain cancer	0.000261	0.000973	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—brain cancer	0.000261	0.000972	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ESR2—brain cancer	0.000259	0.000966	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR2—brain cancer	0.000259	0.000966	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH2—brain cancer	0.000256	0.000954	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000251	0.000937	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH2—brain cancer	0.000245	0.000915	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH2—brain cancer	0.000245	0.000915	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL2—brain cancer	0.000243	0.000906	CbGpPWpGaD
Acitretin—RARG—Gene Expression—SIRT1—brain cancer	0.000243	0.000905	CbGpPWpGaD
Acitretin—RBP1—Disease—APC—brain cancer	0.000237	0.000885	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000232	0.000867	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2C9—brain cancer	0.000227	0.000846	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HES1—brain cancer	0.000225	0.00084	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000222	0.000828	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SIRT1—brain cancer	0.000222	0.000827	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.00022	0.00082	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SIRT1—brain cancer	0.000218	0.000811	CbGpPWpGaD
Acitretin—ALB—Hemostasis—BSG—brain cancer	0.000217	0.00081	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PDGFRA—brain cancer	0.000214	0.000799	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.000214	0.000799	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SIRT1—brain cancer	0.000209	0.000778	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SIRT1—brain cancer	0.000209	0.000778	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SPP1—brain cancer	0.000208	0.000776	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000207	0.000771	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HES1—brain cancer	0.000205	0.000764	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MYC—brain cancer	0.000197	0.000736	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000194	0.000722	CbGpPWpGaD
Acitretin—RXRA—Metabolism—BSG—brain cancer	0.000193	0.00072	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IRS2—brain cancer	0.000188	0.000702	CbGpPWpGaD
Acitretin—RBP1—Disease—ERBB2—brain cancer	0.000184	0.000687	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—brain cancer	0.000181	0.000673	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000178	0.000664	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—brain cancer	0.000177	0.00066	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—brain cancer	0.000177	0.00066	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000174	0.000649	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00017	0.000634	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—brain cancer	0.00017	0.000633	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—brain cancer	0.00017	0.000633	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000169	0.000629	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CG—brain cancer	0.000166	0.00062	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APC—brain cancer	0.000166	0.00062	CbGpPWpGaD
Acitretin—RXRA—Metabolism—IDH1—brain cancer	0.000166	0.000619	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CG—brain cancer	0.000162	0.000604	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—brain cancer	0.000161	0.000601	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CDK4—brain cancer	0.000161	0.000599	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—brain cancer	0.000156	0.000582	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—DNMT1—brain cancer	0.00015	0.000561	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000146	0.000545	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TRPC6—brain cancer	0.000142	0.000531	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—brain cancer	0.000141	0.000524	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000135	0.000504	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR2—brain cancer	0.000135	0.000503	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000131	0.00049	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—brain cancer	0.000131	0.000489	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—brain cancer	0.000131	0.000487	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RELA—brain cancer	0.00013	0.000484	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—brain cancer	0.000129	0.000481	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH2—brain cancer	0.000128	0.000477	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—brain cancer	0.000128	0.000476	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000123	0.000459	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RELA—brain cancer	0.000118	0.000441	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—brain cancer	0.000118	0.000438	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—brain cancer	0.000117	0.000436	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—brain cancer	0.000114	0.000425	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—brain cancer	0.000113	0.000421	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SIRT1—brain cancer	0.000109	0.000405	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VAV1—brain cancer	0.000107	0.000398	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2C9—brain cancer	0.000104	0.000386	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—brain cancer	0.000103	0.000383	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—brain cancer	9.94e-05	0.000371	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—brain cancer	9.84e-05	0.000367	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—brain cancer	9.5e-05	0.000354	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	9.24e-05	0.000345	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—brain cancer	9.15e-05	0.000341	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—brain cancer	9.05e-05	0.000337	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—brain cancer	8.96e-05	0.000334	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—brain cancer	8.95e-05	0.000334	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—brain cancer	8.85e-05	0.00033	CbGpPWpGaD
Acitretin—ALB—Metabolism—BSG—brain cancer	8.8e-05	0.000328	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—brain cancer	8.69e-05	0.000324	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—brain cancer	8.52e-05	0.000318	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—brain cancer	8.17e-05	0.000305	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—brain cancer	8.17e-05	0.000305	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—brain cancer	8.14e-05	0.000304	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	7.86e-05	0.000293	CbGpPWpGaD
Acitretin—ALB—Metabolism—IDH1—brain cancer	7.57e-05	0.000282	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—brain cancer	7.51e-05	0.00028	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—brain cancer	6.77e-05	0.000252	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.16e-05	0.00023	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—brain cancer	6.02e-05	0.000224	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—brain cancer	5.98e-05	0.000223	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—brain cancer	4.76e-05	0.000178	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—brain cancer	4.26e-05	0.000159	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—brain cancer	4.05e-05	0.000151	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—brain cancer	3.06e-05	0.000114	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—brain cancer	2.75e-05	0.000102	CbGpPWpGaD
